Acción 2372 I'ROM GROUP CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas I'rom Group Co., Ltd.

Acciones

2372

JP3105170009

Mercado cerrado - Japan Exchange
Otros sitios de cotización
 08:00:00 16/05/2024 		Varia. Cinco días. Varia. 1 de enero.
2.784 JPY +0,40 % Gráfico intradía de I'rom Group Co., Ltd. +51,88 % +38,58 %
2023 I'rom Group Co. presenta los resultados del ejercicio cerrado el 31 de marzo de 2023 CI
2022 Lupin se alía con el Grupo I'rom para comercializar Denosumab en Japón MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan
Lupin and I'rom Enter into an Exclusive Licensing Agreement for Denosumab Biosimilar for Japan
Cogsmart Co., Ltd. announced that it has received ¥350 million in funding from Omron Ventures Co., Ltd., I'rom Group Co., Ltd., DG Daiwa Ventures Inc., IT-Farm Corporation, Makoto Capital Co., Ltd. and other investors
I'rom Group Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable June 29, 2021 and Provided Dividend Guidance for the Second Quarter and Fiscal Year 2022
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2020; Provides Year End Dividend for the Year Ending March 31, 2020
Tranche Update on I'rom Group Co., Ltd.'s Equity Buyback Plan announced on February 26, 2019.
I'rom Group Co., Ltd.'s Equity Buyback announced on February 26, 2019 has expired with 124,300 shares for ¥199.89 million.
I'rom Group Co., Ltd. announces an Equity Buyback for 130,000 shares, representing 1.12% for ¥200 million.
I'rom Group Co., Ltd. authorizes a Buyback Plan.
Tranche Update on I'rom Group Co., Ltd.'s Equity Buyback Plan announced on November 8, 2018.
I'rom Group Co., Ltd.'s Equity Buyback announced on November 8, 2018 has expired with 89,800 shares for ¥199.86 million.
I'rom Group Co., Ltd. announces an Equity Buyback for 110,000 shares, representing 0.94% for ¥200 million.
I'rom Group Co., Ltd. authorizes a Buyback Plan.
I'rom Group Co., Ltd.(TSE:2372) added to S&P Global BMI Index
An undisclosed buyer cancelled the acquisition of I'rom OK Co., Ltd. from I'rom Group Co., Ltd..
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2017; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2018
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 2018; Declares Dividend for the Second Quarter of Fiscal 2018, Payable on December 15, 2017
OKEIOS Co., Ltd. announced that it has received funding from I'rom Group Co., Ltd.
I'rom Group Co., Ltd. completed the acquisition CMAX Clinical Research Pty Ltd from IDT Australia Limited for AUD 16.2 million.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 2372
  4. Noticias I'rom Group Co., Ltd.
  5. Otros idiomas